Cyclacel receives Nasdaq delisting notice due to equity noncompliance; trading may be suspended Sep 3

Bio Green Med Solution, Inc.

Stockholders' equity was $999K as of June 30, 2024, below Nasdaq's $2.5M minimum for continued listing.
Nasdaq staff determined company failed to show ability to achieve or sustain compliance after prior notice in March 2024.
Unless appeal is requested by Aug 29, 2024, trading of CYCC and CYCCP shares will be suspended at open on Sep 3, 2024.
Management plans to request a hearing before the Nasdaq Hearings Panel, which would temporarily stay delisting.
Previously completed an equity raise of ~$6.3M in May 2024 but still could not regain compliance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.